EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access

Primary Care Utilization and Cardiovascular Screening in Adult Survivors of Childhood Cancer

Timothy J D Ohlsen, Yan Chen, Laura-Mae Baldwin, Melissa M Hudson, Paul C Nathan, Claire Snyder, Karen L Syrjala, Emily S Tonorezos, Yutaka Yasui, Gregory T Armstrong, Kevin C Oeffinger, Eric J Chow

JAMA Network Open · 2023

DOI: 10.1001/jamanetworkopen.2023.47449 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA Network Open, 2023. Verfasst von Timothy J D Ohlsen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Cancer and Blood Disorders Center, Seattle Children's Hospital, University of Washington, Seattle. Hauptthemen laut MEDLINE: Neoplasms, Cancer Survivors, Cardiovascular Diseases, Diabetes Mellitus. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Cardiovascular disease is the leading noncancer cause of premature death among survivors of childhood cancer. Adult survivors of childhood cancer are largely managed by primary care practitioners (PCPs), and health care utilization patterns related to cardiovascular screening are not well described.

Objective

To examine screening and health care utilization among survivors of childhood cancer at high risk for cardiovascular complications. Design, Setting, and Participants This multicenter cross-sectional study included participants enrolled in a randomized clinical trial from 2017 to 2021. Abstracted documentation of participants’ cancer history, cardiotoxic treatment exposures, and survivorship care plans were obtained from participants’ PCPs spanning 2 years preceding trial enrollment. Participants were members of the Childhood Cancer Survivor Study cohort at elevated risk for ischemic heart disease or heart failure, enrolled in a randomized trial focused on improving cardiovascular risk factor control. Data were analyzed from November 2022 to July 2023. Main Outcomes and Measures Outcomes of interest were numbers of PCP and specialist visits, cardiovascular risk factors (hypertension, dyslipidemia, and diabetes), risk factor screening, and cardiac testing. Multivariable logistic regression assessed characteristics associated with up-to-date cardiac testing at enrollment.

Results

Of 347 enrolled participants, 293 (84.4%) had evaluable medical records (median [range] age, 39.9 [21.5-65.0] years; 149 [50.9%] male) and were included in analyses. At baseline, 238 participants (81.2%) had a documented PCP encounter; 241 participants (82.3%) had undergone blood pressure screening, 179 participants (61.1%) had undergone lipid testing, and 193 participants (65.9%) had undergone diabetes screening. A total of 63 participants (21.5%) had echocardiography completed or planned. Only 198 participants (67.6%) had records referencing a cancer history. PCP documentation of prior cardiotoxic exposures was low compared with known exposures, including radiation therapy (103 participants [35.2%] vs 203 participants [69.3%]; P < .001) and anthracycline chemotherapy (27 participants [9.2%] vs 222 participants [75.8%]; P = .008). Few records referenced a need for cancer-related late effects surveillance (95 records [32.4%]). Independent factors associated with cardiac screening included documentation of increased cardiovascular disease risk (odds ratio [OR], 11.94; 95% CI, 3.37-42.31), a late-effects surveillance plan (OR, 3.92; 95% CI, 1.69-9.11), and existing cardiovascular risk factors (OR per each additional factor, 2.09; 95% CI, 1.32-3.31). Conclusions and Relevance This cross-sectional study of adult survivors of childhood cancer at increased risk of cardiovascular disease found low adherence to recommended cardiac testing and documentation of risk for these individuals. Improving accuracy of reporting of survivors’ exposures and risks within the medical record may improve screening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsCancer SurvivorsCardiovascular DiseasesDiabetes MellitusAdultHumansMaleChildFemaleCross-Sectional StudiesEarly Detection of CancerSurvivorsCardiotoxicityPrimary Health Care

Autor:innen und Institutionen

  • Cancer and Blood Disorders Center, Seattle Children's Hospital, University of Washington, Seattle.
  • Fred Hutchinson Cancer Center, Seattle, Washington.
  • University of Alberta, Calgary, Canada.
  • Department of Family Medicine, University of Washington, Seattle.
  • Departments of Oncology and Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, Tennessee.
  • The Hospital for Sick Children, University of Toronto, Toronto, Canada.

Förderung

  • NCI NIH HHS

Zitieren

APA

Ohlsen, T. J. D., Chen, Y., Baldwin, L. M., Hudson, M. M., Nathan, P. C., Snyder, C., Syrjala, K. L., Tonorezos, E. S., Yasui, Y., Armstrong, G. T., Oeffinger, K. C., & Chow, E. J. (2023). Primary Care Utilization and Cardiovascular Screening in Adult Survivors of Childhood Cancer. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2023.47449

Vancouver

Ohlsen TJD, Chen Y, Baldwin LM, Hudson MM, Nathan PC, Snyder C, et al. Primary Care Utilization and Cardiovascular Screening in Adult Survivors of Childhood Cancer. JAMA Network Open. 2023. doi:10.1001/jamanetworkopen.2023.47449

BibTeX
@article{Ohlsen2023,
  author = {Ohlsen, Timothy J D and Chen, Yan and Baldwin, Laura-Mae and Hudson, Melissa M and Nathan, Paul C and Snyder, Claire and Syrjala, Karen L and Tonorezos, Emily S and Yasui, Yutaka and Armstrong, Gregory T and Oeffinger, Kevin C and Chow, Eric J},
  title = {Primary Care Utilization and Cardiovascular Screening in Adult Survivors of Childhood Cancer},
  journal = {JAMA Network Open},
  year = {2023},
  doi = {10.1001/jamanetworkopen.2023.47449}
}
Kostenlos starten →